on 01 Aug 2023
Last Applicant/ Owned by
Paasheuvelweg 25
Amsterdam
NL
1105BP
Serial Number
90788287 filed on 22nd Jun 2021
Registration Number
7123802 registered on 01st Aug 2023
Correspondent Address
Julianne Abelman
Filing Basis
1. intent to use
Disclaimer
NO DATA
Research, product development and consultancy in the field of biotechnology, biologic pharmaceutical preparations, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, Read More
Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics
Research, product development and consultancy in the field of biotechnology, biologic pharmaceutical preparations, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics
Viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical products for the treatment of viral diseases; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy, namely, biological preparations for medical diagnostic or treatment use; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing, namely, reagents for medical use; pharmaceutical preparations, vaccines, prophylaxis products and other products for use in nucleic acid-based therapy, gene therapy and cell therapy
No 90788287
No Service Mark
No 115710.00731
Yes
No
No
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
01st Aug 2023 | REGISTERED-PRINCIPAL REGISTER |
01st Aug 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
26th Jun 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
26th Jun 2023 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
01st May 2023 | TEAS DELETE 1(B) BASIS RECEIVED |
01st May 2023 | NOTICE OF ALLOWANCE CANCELLED |
25th Apr 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
28th Feb 2023 | PUBLISHED FOR OPPOSITION |
28th Feb 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
08th Feb 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |